Healthcare Co., Ltd.
SSE:603313.SS
8 (CNY) • At close May 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 8,449.386 | 7,975.916 | 8,017.245 | 8,139.255 | 6,530.134 | 3,831.588 | 3,049.473 | 2,338.804 | 1,723.034 | 1,377.22 | 1,162.15 | 955.807 | 899.842 | 673.936 |
| Cost of Revenue
| 5,335.596 | 4,948.402 | 5,528.578 | 5,822.051 | 4,315.39 | 2,309.648 | 2,071.119 | 1,647.95 | 1,144.069 | 897.17 | 813.026 | 660.513 | 621.449 | 467.695 |
| Gross Profit
| 3,113.79 | 3,027.515 | 2,488.667 | 2,317.204 | 2,214.744 | 1,521.94 | 978.354 | 690.854 | 578.965 | 480.05 | 349.124 | 295.294 | 278.393 | 206.241 |
| Gross Profit Ratio
| 0.369 | 0.38 | 0.31 | 0.285 | 0.339 | 0.397 | 0.321 | 0.295 | 0.336 | 0.349 | 0.3 | 0.309 | 0.309 | 0.306 |
| Reseach & Development Expenses
| 141.506 | 115.658 | 95.31 | 124.249 | 110.156 | 101.23 | 88.849 | 80.134 | 52.913 | 43.886 | 39.789 | 29.204 | 27.856 | 0 |
| General & Administrative Expenses
| 215.262 | 242.697 | 251.479 | 303.855 | 244.352 | 118.58 | 78.06 | 57.387 | 39.064 | 36.298 | 20.144 | 18.839 | 70.455 | 53.821 |
| Selling & Marketing Expenses
| 1,407.068 | 1,739.933 | 1,437.691 | 1,313.514 | 881.527 | 624.526 | 401.058 | 282.408 | 193.016 | 156.958 | 94.819 | 75.39 | 58.654 | 43.087 |
| SG&A
| 1,622.33 | 1,437.12 | 1,689.17 | 1,617.369 | 1,125.879 | 743.106 | 479.117 | 339.795 | 232.08 | 193.256 | 114.963 | 94.229 | 129.11 | 96.908 |
| Other Expenses
| 1,642.98 | 0 | 397.199 | 367.334 | 205.325 | 105.655 | -28.405 | 0.727 | 20.187 | -0.057 | -0.008 | 3.522 | 6.349 | 3.634 |
| Operating Expenses
| 3,406.816 | 2,890.649 | 2,181.679 | 2,108.952 | 1,441.36 | 949.991 | 652.802 | 469.686 | 352.945 | 289.747 | 195.042 | 155.177 | 135.44 | 98.808 |
| Operating Income
| -293.026 | 482.903 | 341.994 | -4.974 | 515.277 | 495.999 | 241.753 | 183.895 | 225.78 | 193.1 | 147.051 | 127.091 | 132.79 | 91.638 |
| Operating Income Ratio
| -0.035 | 0.061 | 0.043 | -0.001 | 0.079 | 0.129 | 0.079 | 0.079 | 0.131 | 0.14 | 0.127 | 0.133 | 0.148 | 0.136 |
| Total Other Income Expenses Net
| 128.775 | -318.437 | -175.988 | -269.189 | -40.685 | -2.679 | -56.131 | -0.604 | 13.459 | 3.398 | -5.262 | -5.193 | -4.829 | 3.614 |
| Income Before Tax
| -164.251 | 164.466 | 81.373 | -274.164 | 474.592 | 493.32 | 241.71 | 183.291 | 239.239 | 196.498 | 149.184 | 130.134 | 138.123 | 95.253 |
| Income Before Tax Ratio
| -0.019 | 0.021 | 0.01 | -0.034 | 0.073 | 0.129 | 0.079 | 0.078 | 0.139 | 0.143 | 0.128 | 0.136 | 0.153 | 0.141 |
| Income Tax Expense
| 14.712 | 42.929 | 29.401 | -4.526 | 57.938 | 101.113 | 45.055 | 29.86 | 40.632 | 31.497 | 17.92 | 20.686 | 23.071 | 15.056 |
| Net Income
| -151.42 | 106.601 | 41.359 | -269.638 | 378.586 | 373.677 | 186.073 | 155.849 | 200.396 | 164.261 | 130.825 | 108.137 | 113.973 | 80.393 |
| Net Income Ratio
| -0.018 | 0.013 | 0.005 | -0.033 | 0.058 | 0.098 | 0.061 | 0.067 | 0.116 | 0.119 | 0.113 | 0.113 | 0.127 | 0.119 |
| EPS
| -0.27 | 0.22 | 0.085 | -0.56 | 0.85 | 0.91 | 0.46 | 0.38 | 0.61 | 0.54 | 0.43 | 0.36 | 0.37 | 1.45 |
| EPS Diluted
| -0.27 | 0.22 | 0.085 | -0.56 | 0.85 | 0.87 | 0.46 | 0.38 | 0.61 | 0.54 | 0.43 | 0.36 | 0.37 | 1.45 |
| EBITDA
| 574.967 | 884.173 | 918.51 | 355.094 | 830.945 | 613.695 | 332.357 | 246.214 | 279.223 | 220.556 | 167.62 | 147.408 | 142.953 | 114.314 |
| EBITDA Ratio
| 0.068 | 0.111 | 0.115 | 0.044 | 0.127 | 0.16 | 0.109 | 0.105 | 0.162 | 0.16 | 0.144 | 0.154 | 0.159 | 0.17 |